A Phase Ib, Double Blind RCT to Evaluate and Compare the PK, PD and Safety of MabThera With TL011, in Combination With CHOP, in Subjects With CD20+ DLBCL.
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2013
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Pharmacokinetics
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 May 2013 Planned End Date changed from 1 Apr 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov record.
- 25 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.